CIK 0001075880 · Non-accelerated filer
KAZIA THERAPEUTICS LTD
Sign in to watch- Ticker
- KZIA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- operating
- Phone
- 01161298780088
- Business address
- THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, Australia, 2000
- Former names
- NOVOGEN LTD
- 6-K Event Report of Foreign Issuer
- D Other Notice of Sales of Unregistered Securities
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- NT 20-F Other Notification of Inability to Timely File
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 6-K Event Report of Foreign Issuer
Page 7 of 60 · 1,191 filings